Five things for pharma marketers to know: Thursday, April 28, 2016
1. Pfizer will pay $784 million to settle allegations that its subsidiary Wyeth concealed drug discounts to avoid paying Medicare rebates. A lawsuit alleged that Wyeth gave many hospitals discounts for two proton pump inhibitors, Protonix Oral and Protonix IV. (Modern Healthcare)
2. Sanofi is attempting to acquire Medivation for approximately $9.3 billion. Medivation is known for its cancer portfolio and prostate cancer drug Xtandi. AstraZeneca is also reportedly considering making an offer for Medivation.
3. AstraZeneca sold the US rights to gout drug Zurampic to Ironwood Pharmaceuticals in a deal worth up to $265 million. (Reuters)
4. The attorney general of New York will require seven health insurers to cover hepatitis-C medications for almost all patients who have commercial insurance plans in the state. (WSJ)
5. Cindy Whitehead, formerly CEO of Sprout Pharmaceuticals, is launching a new company. The Pink Ceiling will partner with startups that cater their products or services to women. (Fortune)